Ikarian Capital’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139K | Hold |
|
|||||
|
2025
Q2 | $190K | Sell |
|
|||||
|
2025
Q1 | $134K | Hold |
|
|||||
|
2024
Q4 | $218K | Buy |
|
|||||
|
2024
Q3 | $272K | Hold |
|
|||||
|
2024
Q2 | $292K | Hold |
|
|||||
|
2024
Q1 | $6.57M | Sell |
|
|||||
|
2023
Q4 | $6.57M | Hold |
|
|||||
|
2023
Q3 | $4.9M | Buy |
|
|||||
|
2023
Q2 | $4.02M | Buy |
|
|||||
|
2023
Q1 | $711K | Hold |
|
|||||
|
2022
Q4 | $1.08M | Hold |
|
|||||
|
2022
Q3 | $1.72M | Sell |
|
|||||
|
2022
Q2 | $1.96M | Sell |
|
|||||
|
2022
Q1 | $1.7M | Buy |
|
|||||
|
2021
Q4 | $1.72M | Sell |
|
|||||
|
2021
Q3 | $3.69M | Sell |
|
|||||
|
2021
Q2 | $5.02M | Sell |
|
|||||
|
2021
Q1 | $9.05M | Sell |
|
|||||
|
2020
Q4 | $9.29M | Buy |
|
|||||
|
2020
Q3 | $4.34M | Buy |
|